The impact of high-fat diet on metabolism and immune defense in small intestine mucosa

Journal of Proteome Research

Volumn 14, Issue 1, 2015, Pages 353-365

  Wis̈niewski, Jacek R ^a   Friedrich, Alexandra ^b   Keller, Thorsten ^b   Mann, Matthias ^a   Koepsell, Hermann ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

drug transport; high fat diet; immune defense; intestinal epithelium; intestinal metabolism; major histocompatibility complex (MHC); nutrient transport; nutrition; proteomics; Small intestine

Indexed keywords

ABC TRANSPORTER G5; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BREAST CANCER RESISTANCE PROTEIN; FATTY ACID; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; PEPTIDE TRANSPORTER 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SODIUM GLUCOSE COTRANSPORTER 1; CARRIER PROTEIN; PROTEOME; STEROID;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE DIET; CELL ADHESION; CELL CONTACT; CELL MEMBRANE; CELL TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; DRUG METABOLISM; FAT INTAKE; FATTY ACID OXIDATION; GLYCOLYSIS; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INTESTINE CELL; LIPID ABSORPTION; LIPID DIET; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; METABOLISM; MOUSE; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PROTEIN DIET; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; PROTEOMICS; RESPIRATORY CHAIN; SMALL INTESTINE MUCOSA; STEROID METABOLISM; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; LIQUID CHROMATOGRAPHY; PHYSIOLOGY; PROCEDURES; SMALL INTESTINE; TANDEM MASS SPECTROMETRY;

MUS;

ANIMALS; CARRIER PROTEINS; CHROMATOGRAPHY, LIQUID; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY ACIDS; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; MICE, INBRED BALB C; PROTEOME; PROTEOMICS; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 84920263464     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500833v     Document Type: Article

References (43)

1. Koepsell, H. The SLC22 family with transporters of organic cations, anions, and zwitterions Mol. Aspects Med. 2013, 34, 413-435
2. Suzuki, H.; Sugiyama, Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine Eur. J. Pharm. Sci. 2000, 12, 3-12
3. Kaminsky, L. S.; Zhang, Q. Y. The small intestine as a xenobiotic-metabolizing organ Drug Metab. Dispos. 2003, 31, 1520-1525
4. McConnell, R. E.; Benesh, A. E.; Mao, S.; Tabb, D. L.; Tyska, M. J. Proteomic analysis of the enterocyte brush border Am. J. Physiol.: Gastrointest. Liver Physiol. 2011, 300, G914-G926
5. Donowitz, M.; Singh, S.; Salahuddin, F. F.; Hogema, B. M.; Chen, Y.; Gucek, M.; Cole, R. N.; Ham, A.; Zachos, N. C.; Kovbasnjuk, O.; Lapierre, L. A.; Broere, N.; Goldenring, J.; deJonge, H.; Li, X. Proteome of murine jejunal brush border membrane vesicles J. Proteome Res. 2007, 6, 4068-4079
6. Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis Nat. Methods 2009, 6, 359-362
7. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies, and proteome-wide protein quantification Nat. Biotechnol. 2008, 26, 1367-1372
8. Wisniewski, J. R.; Mann, M. Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis Anal. Chem. 2012, 84, 2631-2637
9. Wisniewski, J. R.; Zielinska, D. F.; Mann, M. Comparison of ultrafiltration units for proteomic and N -glycoproteomic analysis by the filter-aided sample preparation method Anal. Biochem. 2011, 410, 307-309
10. Wisniewski, J. R.; Zougman, A.; Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome J. Proteome Res. 2009, 8, 5674-5678
11. Olsen, J. V.; Macek, B.; Lange, O.; Makarov, A.; Horning, S.; Mann, M. Higher-energy C-trap dissociation for peptide modification analysis Nat. Methods 2007, 4, 709-712
12. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: A peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10, 1794-1805
13. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing J. R. Stat. Soc. 1995, 57, 289-300
14. Wisniewski, J. R.; Ostasiewicz, P.; Dus, K.; Zielinska, D. F.; Gnad, F.; Mann, M. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma Mol. Syst. Biol. 2012, 8, 611
15. Benhamed, F.; Denechaud, P. D.; Lemoine, M.; Robichon, C.; Moldes, M.; Bertrand-Michel, J.; Ratziu, V.; Serfaty, L.; Housset, C.; Capeau, J.; Girard, J.; Guillou, H.; Postic, C. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans J. Clin. Invest. 2012, 122, 2176-2194
16. Gorboulev, V.; Schürmann, A.; Vallon, V.; Kipp, H.; Jaschke, A.; Klessen, D.; Friedrich, A.; Scherneck, S.; Rieg, T.; Cunard, R.; Veyhl-Wichmann, M.; Srinivasan, A.; Balen, D.; Breljak, D.; Rexhepaj, R.; Parker, H. E.; Gribble, F. M.; Reimann, F.; Lang, F.; Wiese, S.; Sabolic, I.; Sendtner, M.; Koepsell, H. Na+- d -glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion Diabetes 2012, 61, 187-196
17. Anderson, C. M.; Stahl, A. SLC27 fatty acid transport proteins Mol. Aspects Med. 2013, 34, 516-528
18. Traiffort, E.; O'Regan, S.; Ruat, M. The choline transporter-like family SLC44: Properties and roles in human diseases Mol. Aspects Med. 2013, 34, 646-654
19. Koepsell, H.; Lips, K.; Volk, C. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications Pharm. Res. 2007, 24, 1227-1251
20. Benet, L. Z.; Cummins, C. L. The drug efflux-metabolism alliance: Biochemical aspects Adv. Drug Delivery Rev. 2001, 50 (Suppl. 1) S3-S11
21. Ding, X.; Kaminsky, L. S. Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts Annu. Rev. Pharmacol. Toxicol. 2003, 43, 149-173
22. Paine, M. F.; Hart, H. L.; Ludington, S. S.; Haining, R. L.; Rettie, A. E.; Zeldin, D. C. The human intestinal cytochrome P450 "pie" Drug Metab. Dispos. 2006, 34, 880-886
23. Miron, N.; Cristea, V. Enterocytes: Active cells in tolerance to food and microbial antigens in the gut Clin. Exp. Immunol. 2012, 167, 405-412
24. Ostman, S.; Taube, M.; Telemo, E. Tolerosome-induced oral tolerance is MHC-dependent Immunology 2005, 116, 464-476
25. Hansen, G. H.; Niels-Christiansen, L. L.; Immerdal, L.; Danielsen, E. M. Antibodies in the small intestine: Mucosal synthesis and deposition of anti-glycosyl IgA, IgM, and IgG in the enterocyte brush border Am. J. Physiol.: Gastrointest. Liver Physiol. 2006, 291, G82-G90
26. Baumgart, D. C.; Carding, S. R. Inflammatory bowel disease: Cause and immunobiology Lancet 2007, 369, 1627-1640
27. Xavier, R. J.; Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease Nature 2007, 448, 427-434
28. Chang, C. T.; Ho, T. Y.; Lin, H.; Liang, J. A.; Huang, H. C.; Li, C. C.; Lo, H. Y.; Wu, S. L.; Huang, Y. F.; Hsiang, C. Y. 5-Fluorouracil-induced intestinal mucositis via nuclear factor-kappaB activation by transcriptomic analysis and in vivo bioluminescence imaging PLoS One 2012, 7, e31808
29. Han, T. K.; Everett, R. S.; Proctor, W. R.; Ng, C. M.; Costales, C. L.; Brouwer, K. L.; Thakker, D. R. Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes Mol. Pharmacol. 2013, 84, 182-189
30. Shugarts, S.; Benet, L. Z. The role of transporters in the pharmacokinetics of orally administered drugs Pharm. Res. 2009, 26, 2039-2054
31. Ferraris, R. P.; Diamond, J. M. Specific regulation of intestinal nutrient transporters by their dietary substrates Annu. Rev. Physiol. 1989, 51, 125-141
32. Forster, I. C.; Hernando, N.; Biber, J.; Murer, H. Phosphate transporters of the SLC20 and SLC34 families Mol. Aspects Med. 2013, 34, 386-395
33. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 Diabetes Care 2004, 27, 1047-1053
34. Guh, D. P.; Zhang, W.; Bansback, N.; Amarsi, Z.; Birmingham, C. L.; Anis, A. H. The incidence of comorbidities related to obesity and overweight: A systematic review and meta-analysis BMC Public Health 2009, 9, 88
35. Winzell, M. S.; Ahren, B. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes Diabetes 2004, 53 (Suppl. 3) S215-S219
36. Ding, S.; Chi, M. M.; Scull, B. P.; Rigby, R.; Schwerbrock, N. M.; Magness, S.; Jobin, C.; Lund, P. K. High-fat diet: Bacteria interactions promote intestinal inflammation, which precedes and correlates with obesity and insulin resistance in mouse PLoS One 2010, 5, e12191
37. Paine, M. F.; Shen, D. D.; Kunze, K. L.; Perkins, J. D.; Marsh, C. L.; McVicar, J. P.; Barr, D. M.; Gillies, B. S.; Thummel, K. E. First-pass metabolism of midazolam by the human intestine Clin. Pharmacol. Ther. 1996, 60, 14-24
38. Kruijtzer, C. M.; Beijnen, J. H.; Rosing, H.; ten Bokkel Huinink, W. W.; Schot, M.; Jewell, R. C.; Paul, E. M.; Schellens, J. H. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P -glycoprotein inhibitor GF120918 J. Clin. Oncol. 2002, 20, 2943-2950
39. Ni, Z.; Bikadi, Z.; Rosenberg, M. F.; Mao, Q. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2) Curr. Drug Metab. 2010, 11, 603-617
40. Young, L. C.; Campling, B. G.; Voskoglou-Nomikos, T.; Cole, S. P.; Deeley, R. G.; Gerlach, J. H. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response Clin. Cancer Res. 1999, 5, 673-680
41. van der Sandt, I. C.; Blom-Roosemalen, M. C.; de Boer, A. G.; Breimer, D. D. Specificity of doxorubicin versus rhodamine-123 in assessing P -glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1, and Caco-2 cell lines Eur. J. Pharm. Sci. 2000, 11, 207-214
42. Redinbo, M. R.; Potter, P. M. Mammalian carboxylesterases: From drug targets to protein therapeutics Drug Discovery Today 2005, 10, 313-325
43. Haselbeck, R. J.; Duester, G. Regional restriction of alcohol/retinol dehydrogenases along the mouse gastrointestinal epithelium Alcohol.: Clin. Exp. Res. 1997, 21, 1484-1490